Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2005-08-18 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CAEN (14000), Calvados
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE L ORNE : revenue, balance sheet and financial ratios
PHARMACIE DE L ORNE is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CAEN (14000),
this company of category PME
shows in 2022 a revenue of 3.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE L ORNE (SIREN 483784039)
Indicator
2024
2023
2022
2021
2020
2019
2018
2016
Revenue
N/C
N/C
3 191 862 €
N/C
N/C
N/C
N/C
N/C
Net income
145 873 €
79 985 €
273 429 €
214 678 €
75 984 €
76 989 €
82 423 €
85 014 €
EBITDA
N/C
N/C
362 459 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
8.6%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE L ORNE generates positive net income of 146 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 85 k€ -> 146 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
145 873 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 33%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
33.42%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
57.508%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
2020
2021
2022
2023
2024
Debt ratio
1107.043
372.17
265.95
197.986
89.551
62.123
46.242
33.42
Financial autonomy
7.04
17.578
22.468
28.087
41.545
47.988
54.091
57.508
Repayment capacity
None
None
None
None
None
1.962
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
9.027%
None%
None%
Sector positioning
Debt ratio
33.422024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good-9 pts over 3 years
In 2024, the debt ratio of PHARMACIE DE L ORNE (33.42) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
57.51%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+8 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE L ORNE (57.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
1.96 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of PHARMACIE DE L ORNE (1.96) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 147.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
147.359
Liquidity indicators evolution PHARMACIE DE L ORNE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
178.962
173.768
171.465
188.016
198.309
201.645
206.777
147.359
Interest coverage
None
None
None
None
None
1.46
None
None
Sector positioning
Liquidity ratio
147.362024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average-17 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE L ORNE (147.36) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
1.46x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE DE L ORNE (1.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE L ORNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
502 910 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
43
0
0
Customer payment term (days)
94
0
0
0
0
4
0
0
Supplier payment term (days)
598
0
0
0
0
54
0
0
Positioning of PHARMACIE DE L ORNE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE L ORNE is estimated at
2 036 494 €
(range 1 418 182€ - 3 046 712€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1418k€2036k€3046k€
2 036 494 €Range: 1 418 182€ - 3 046 712€
NAF 5 année 2024
Valuation method used
Net Income Multiple
145 873 €
×
14.0x
=2 036 495 €
Range: 1 418 183€ - 3 046 713€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE L ORNE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE L ORNE
What is the revenue of PHARMACIE DE L ORNE ?
The revenue of PHARMACIE DE L ORNE in 2022 is 3.2 M€.
Is PHARMACIE DE L ORNE profitable?
Yes, PHARMACIE DE L ORNE generated a net profit of 146 k€ in 2024.
Where is the headquarters of PHARMACIE DE L ORNE ?
The headquarters of PHARMACIE DE L ORNE is located in CAEN (14000), in the department Calvados.
Where to find the tax return of PHARMACIE DE L ORNE ?
The tax return of PHARMACIE DE L ORNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE L ORNE operate?
PHARMACIE DE L ORNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart